Ilex Capital Partners’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.8M Sell
289,131
-316,212
-52% -$46.3M 1.04% 33
2026
Q1
$74.6M Buy
605,343
+308,420
+104% +$40.5M 1.84% 21
2025
Q4
$38.9M Sell
296,923
-385,484
-56% -$45.3M 1.1% 32
2025
Q3
$64.8M Buy
682,407
+528,288
+343% +$52.4M 2.07% 17
2025
Q2
$14.7M Buy
154,119
+135,709
+737% +$11M 0.49% 40
2025
Q1
$1.46M Buy
+18,410
New +$1.99M 0.06% 149

Other funds holding ILMN

Ilex Capital Partners's ILMN Position: Q2 2026 in Review

Ilex Capital Partners reduced its Illumina (ILMN) stake by 52% in Q2 2026, selling an estimated $46.3M and leaving 289,131 shares worth $50.8M. The position accounts for 1.04% of the portfolio, ranked #33.

Ilex Capital Partners first reported a position in ILMN in Q1 2025 and has held it in 6 quarters since. The position peaked at $74.6M in Q1 2026. 937 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Ilex Capital Partners held 289,131 shares of Illumina worth $50.8M as of Q2 2026.
  • Ilex Capital Partners sold 316,212 Illumina shares in Q2 2026, an estimated $46.3M.
  • Illumina made up 1.04% of Ilex Capital Partners's portfolio in Q2 2026, its #33 holding.
  • Ilex Capital Partners first reported a position in Illumina in Q1 2025 and has held it in 6 quarters since.
  • Ilex Capital Partners's Illumina position peaked at $74.6M in Q1 2026.
  • 937 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.